# K230467: BTL-899F

- Pathway: 510(k) (Traditional)
- Applicant: BTL Industries, Inc.
- Decided: Sep 21, 2023 after 212 days
- Product code: GEI (Electrosurgical, Cutting & Coagulation & Accessories)
- Device class: 2
- Regulation: 21 CFR 878.4400
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 22 generations back to K943450 (1995). 109 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 111 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K213344: BTL-899A, BTL Industries, Inc. (2022) Summary page 4.

## Most influential descendants
- K233849: BTL-499 (2024), 0 descendants of its own

## Indications for use
BTL-899F is indicated to be used for: • Non-invasive lipolysis (breakdown of fat) of the abdomen. • Reduction in circumference of the abdomen. • Non-invasive lipolysis (breakdown of fat) of the thighs. • Reduction in circumference of the thighs. • BTL-899F is intended for use with skin types I – VI. • Non-invasive lipolysis (breakdown of fat) of the flanks limited to skin types I - IV. • Non-invasive lipolysis (breakdown of fat) of the upper arms limited to skin types II and III and BMI 30 and under.

Source page: https://510kreport.com/device/K230467
Methodology: https://510kreport.com/methodology